Building Biomedical Engineering Education, Research, and Innovation at Historically Black Colleges and Universities (HBCU eBETA) (UG3/UH3 Clinical Trial Not Allowed)

The summary for the Building Biomedical Engineering Education, Research, and Innovation at Historically Black Colleges and Universities (HBCU eBETA) (UG3/UH3 Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Building Biomedical Engineering Education, Research, and Innovation at Historically Black Colleges and Universities (HBCU eBETA) (UG3/UH3 Clinical Trial Not Allowed): The purpose of the Historically Black Colleges and Universities (HBCUs) Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) program is to enhance bioengineering and imaging research capacity, technology innovation, education and research training, and opportunities for scientific growth at HBCUs in order to utilize the Nation's full range of talent in meeting the growing need to accelerate the development and translation of high-impact biomedical innovation and technologies. The HBCU BEITA initiative will provide funding to strengthen the research capacity and technology innovation at HBCUs, accelerate technology development and implementation, and prepare students at HBCUs for careers in biomedical engineering, imaging, and technology (BEIT).

Federal Grant Title:	Building Biomedical Engineering Education, Research, and Innovation at Historically Black Colleges and Universities (HBCU eBETA) (UG3/UH3 Clinical Trial Not Allowed)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-EB-25-002
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.286
CFDA Descriptions:	Information not provided
Current Application Deadline:	September 30th, 2025
Original Application Deadline:	September 30th, 2025
Posted Date:	October 15th, 2024
Creation Date:	October 15th, 2024
Archive Date:	November 5th, 2025
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	October 15th, 2024

Applicants Eligible for this Grant: Public and State controlled institutions of higher education - Private institutions of higher education - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: Other Eligible Applicants include the following: Historically Black Colleges and Universities (HBCUs); Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Link to Full Grant Announcement: https://grants.nih.gov/grants/guide/rfa-files/RFA-EB-25-002.html
Grant Announcement Contact: NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants: • Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional); • New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Opt...; • Bioengineering Partnerships with Industry (U01 Clinical Trial Optional); • High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed); • Exploratory Grants (P20) for NIBIB Quantum Projects; • Nibib Research Supplements to Promote Clinical Resident Research Experiences; • Innovation in Molecular Imaging Probes
More Grants from the National Institutes of Health: • Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiologi...; • Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required); • Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Not ...; • Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required); • Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P5...